Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation

Clinical trial NCT03746782 · COMPLETED

Trial details

NCT number: NCT03746782
Sponsor: CirQuest Labs, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Coronary Syndrome

Start date: 2018-07-10
Primary completion: 2019-11-08
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.